Color Blindness Prevalence

Color blindness or color vision deficiency affects about 2.7 million people in Britain. In many individuals, the condition is mild and a person is unaware there is a problem with their color perception until it is detected during a vision test. Other people, however, may notice that they see slightly different shades or hues of colors to those that other people see.

Prevalence

One of the most common forms of inherited color vision deficiency is the red–green deficiency or deuteranopia. This type of color blindness is passed on via the X chromosome and is more common in men who have only the one X chromosome, than in women, who have two X chromosomes. In men, the prevalence of color blindness is around 5.0% to 8.0%, while in women the prevalence is only 0.5% to 1.0%.

Since female offspring always receive one X chromosome from their mother and one from their father, a color blind father always transmits the gene for color blindness to any daughters he may have. These daughters then become carriers of the gene and have a 50% chance of passing the abnormal gene to their sons. A color blind man cannot transmit the condition to his male offspring, since the male always inherits the mother’s X chromosome.

Worldwide prevalence

In Australia, around 8.0% of the male population is color blind compared to around 0.4% of the female population.

In countries where there are isolated communities with limited gene pools, the prevalence may be increased, including that of the more rare forms. Examples of countries with such communities include rural areas of Hungary, Finland and some Scottish islands.

According to 2006 estimates from the Howard Hughes Medical Institute, around 7.0% of the male population and 0.4% of the female population cannot differentiate between red and green or they perceive red and green differently to other people. Overall, nearly all (95%) color vision deficiencies involve abnormal perception of red and green colors and it is uncommon for men or women to have difficulty perceiving the blue end of the color spectrum.

Further Reading

Last Updated: Jul 6, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 06). Color Blindness Prevalence. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/health/Color-Blindness-Prevalence.aspx.

  • MLA

    Mandal, Ananya. "Color Blindness Prevalence". News-Medical. 21 November 2024. <https://www.news-medical.net/health/Color-Blindness-Prevalence.aspx>.

  • Chicago

    Mandal, Ananya. "Color Blindness Prevalence". News-Medical. https://www.news-medical.net/health/Color-Blindness-Prevalence.aspx. (accessed November 21, 2024).

  • Harvard

    Mandal, Ananya. 2023. Color Blindness Prevalence. News-Medical, viewed 21 November 2024, https://www.news-medical.net/health/Color-Blindness-Prevalence.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.